Literature DB >> 3135746

Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.

G L Daikos1, S B Kathpalia, V T Lolans, G G Jackson, E Fosslien.   

Abstract

Acute septic infective endocarditis caused by Pseudomonas aeruginosa, in two patients with conditions that made it incurable, was treated with long-term orally administered ciprofloxacin. Bacteremia and symptoms cleared, resulting in subjective well-being without cure for three and one half and 22 months, respectively. Large amounts of ciprofloxacin, 150 and 1,440 g, respectively, were given continuously without apparent adverse reactions. Blood isolates of P. aeruginosa after treatment had limited progression of resistance to ciprofloxacin. Use of orally administered ciprofloxacin provides new opportunities for the long-term treatment of serious infections with restricted risk of bacterial drug resistance and no appreciable side effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135746     DOI: 10.1016/0002-9343(88)90122-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Infection of a pacemaker by Brucella melitensis.

Authors:  A de la Fuente; J R Sanchez; J Uriz; J Reparaz; J L Lopez-Coronado; I Moriones
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Successful treatment of Brucella melitensis endocarditis with pefloxacin.

Authors:  A Micozzi; M Venditti; G Gentile; N Alessandri; M Santero; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

4.  Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.

Authors:  Tiffanny Jones; Michael R Yeaman; George Sakoulas; Soo-Jin Yang; Richard A Proctor; Hans-Georg Sahl; Jacques Schrenzel; Yan Q Xiong; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 5.  Evaluation of quinolones in experimental animal models of infections.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

6.  Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.

Authors:  C Thauvin; F Lecomte; I Le Boete; G Grise; J F Lemeland
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

Review 7.  Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.

Authors:  A S Bayer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.